Litcius/Paper detail

Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol

Mary W. Redman, Vassiliki A. Papadimitrakopoulou, Katherine Minichiello, Fred R. Hirsch, Philip C. Mack, Lawrence H. Schwartz, Everett E. Vokes, Suresh S. Ramalingam, Natasha B. Leighl, J.D. Bradley, Jieling Miao, James Moon, Louise Highleyman, Crystal Miwa, Michael LeBlanc, Shakun Malik, Vincent A. Miller, Ellen V. Sigal, Stacey J. Adam, David Wholley, Caroline C. Sigman, Beverly D. Smolich, Charles D. Blanke, Karen Kelly, David R. Gandara, Roy S. Herbst

2020The Lancet Oncology124 citationsDOIOpen Access PDF

Topics & Concepts

BiomarkerMedicineLung cancerOncologyInternal medicineClinical trialCancerBiochemistryChemistryLung Cancer Treatments and MutationsCancer Immunotherapy and BiomarkersLung Cancer Diagnosis and Treatment
Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol | Litcius